Increasing bowel cancer screening using SMS in general practice: the SMARTscreen trial.

Jennifer G WalkerMark A JenkinsAnna WoodPatty ChondrosTina CampbellEdweana WenkartClare O'ReillyIan DixonJulie TonerJaviera Martinez GutierrezLinda GovanJon David Emery

Published in: The British journal of general practice : the journal of the Royal College of General Practitioners (2023)

The SMS increased NBCSP kit return in 50-to-60-year-old general practice patients. This finding informed a larger trial -SMARTERscreen- to test this intervention in a broader Australian population.

Keyphrases

general practice
primary care
study protocol
phase iii
clinical trial
randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
phase ii
prognostic factors
papillary thyroid
open label
squamous cell carcinoma
patient reported outcomes
childhood cancer